A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients von Pivot, X., Koralewski, P., Hidalgo, J.L., Chan, A., Gonçalves, A., Schwartsmann, G., Assadourian, S., Lotz, J.P.

Volltext

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer von Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Stahl, E., Clarke, N.W., Claßen, J., Cohn-Cedermark, G., Dahl, A.A., Daugaard, G., De Giorgi, U., De Santis, M., De Wit, M., De Wit, R., Dieckmann, K.P., Fenner, M., Fizazi, K., Flechon, A., Fossa, S.D., Germá Lluch, J.R., Gietema, J.A., Gillessen, S., Giwercman, A., Hartmann, J.T., Heidenreich, A., Hentrich, M., Honecker, F., Horwich, A., Huddart, R.A., Kliesch, S., Kollmannsberger, C., Krege, S., Laguna, M.P., Looijenga, L.H.J., Lorch, A., Lotz, J.P., Mayer, F., Necchi, A., Nicolai, N., Nuver, J., Oechsle, K., Oldenburg, J., Oosterhuis, J.W., Powles, T., Rajpert-De Meyts, E., Rick, O., Rosti, G., Salvioni, R., Schrader, M., Schweyer, S., Sedlmayer, F., Sohaib, A., Souchon, R., Tandstad, T., Winter, C., Wittekind, C.

Volltext

Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer von Selle, F, Gligorov, J, Richard, S, Khalil, A, Alexandre, I, Avenin, D, Provent, S, Soares, D G, Lotz, J P

Volltext

CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer von André, T, Louvet, C, Maindrault-Goebel, F, Couteau, C, Mabro, M, Lotz, J.P, Gilles-Amar, V, Krulik, M, Carola, E, Izrael, V, de Gramont, A

Volltext

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6) von Maindrault-Goebel, F, Louvet, C, André, T, Carola, E, Lotz, J.P, Molitor, J.L, Garcia, M.L, Gilles-Amar, V, Izrael, V, Krulik, M, de Gramont, A

Volltext

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study von André, T., Tournigand, C., Rosmorduc, O., Provent, S., Maindrault-Goebel, F., Avenin, D., Selle, F., Paye, F., Hannoun, L., Houry, S., Gayet, B., Lotz, J. P., de Gramont, A., Louvet, C.

Volltext

A rational approach for salvage of testicular cancer patients von Selle, F., Soares, D.G., Lotz, J.P.

Volltext

Multimodal image-guided electrochemotherapy of unresectable liver metastasis from renal cell cancer von Cornelis, F.H., Korenbaum, C., Ben Ammar, M., Tavolaro, S., Nouri-Neuville, M., Lotz, J.P.

Volltext

Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network von Derquin, F., Floquet, A., Hardy-Bessard, A.C., Edeline, J., Lotz, J.P., Alexandre, J., Pautier, P., Angeles, M.A., Delanoy, N., Lefeuvre-Plesse, C., Cancel, M., Treilleux, I., Augereau, P., Lavoue, V., Kalbacher, E., Berton Rigaud, D., Selle, F., Nadeau, C., Gantzer, J., Joly, F., Guillemet, C., Pomel, C., Favier, L., Abdeddaim, C., Venat-Bouvet, L., Provansal, M., Fabbro, M., Kaminsky, M.C., Lortholary, A., Lecuru, F., Coquard, I. Ray, de La Motte Rouge, T.

Volltext

Impact of a pharmaceutical consultation: Review of a pilot study von Clou, E., Gaudas, J., Ahmed, K., Avenin, D., Esteso, A., Galula, G., Fillon, J., Lotz, J.P., Debrix, I.

Volltext

Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE von Thariat, J., Schouman, T., Brouchet, A., Sarini, J., Miller, R.C., Reychler, H., Ray-Coquard, I., Italiano, A., Verite, C., Sohawon, S., Bompas, E., Dassonville, O., Salas, S., Aldabbagh, K., Maingon, P., de La MotteRouge, T., Kurtz, J.E., Usseglio, J., Kerbrat, P., Raoul, G., Lotz, J.P., Bar-Sela, G., Brugières, L., Chaigneau, L., Saada, E., Odin, G., Marcy, P.Y., Thyss, A., Julieron, M.

Volltext

Breast cancer prognosis after neoadjuvant chemotherapy for breast cancers: molecular downstaging, proliferation, and endocrine sensitivity importance von Benderra, M.-A., Richard, S., Antoine, M., Buob, D., Zilberman, S., Esteso, A., Lotz, J.P., Kerrou, K., Gligorov, J.

Volltext

A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemothera... von Selle, F., Wittnebel, S., Biron, P., Gravis, G., Roubaud, G., Bui, B.N., Delva, R., Bay, J.O., Fléchon, A., Geoffrois, L., Caty, A., Soares, D.G., de Revel, T., Fizazi, K., Gligorov, J., Micléa, J.M., Dubot, C., Provent, S., Temby, I., Gaulet, M., Horn, E., Brindel, I., Lotz, J.P.

Volltext

492 Chemotherapy and bevacizumab combinations in second-line or more for metastatic breast cancer: efficacy and toxicity results von Fillette, A, Guerin, C, Debrix, I, Selle, F, Ontkova, M, Beerblock, K, Avenin, D, Esteso, A, Lotz, J.P, Gligorov, J

Volltext

High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial von Bui-Nguyen, B., Ray-Coquard, I., Chevreau, C., Penel, N., Bay, J.O., Coindre, J.M., Cupissol, D., Italiano, A., Bonichon, F., Lotz, J.P., Thyss, A., Jimenez, M., Mathoulin-Pélissier, S., Blay, J.Y.

Volltext

Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma von André, T., Lotz, J. P., Bouleuc, C., Azzouzi, K., Houry, S., Hannoun, L., See, J., Esteso, A., Avenin, D., Izrael, V.

Volltext

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7) von Maindrault-Gœbel, F, de Gramont, A, Louvet, C, André, T, Carola, E, Mabro, M, Artru, P, Gilles, V, Lotz, J.P, Izrael, V, Krulik, M

Volltext

Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer von F. Selle, J. Gligorov, S. Richard, A. Khalil, I. Alexandre, D. Avenin, S. Provent, D.G. Soares, J.P. Lotz

Volltext

Erratum to “High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as a second-line therapy for metastatic colorectal cancer (FOLFO... von Maindrault-Gœbel, F., de Gramont, A., Louvet, C., André, T., Carola, E., Mabro, M., Artru, P., Gilles, V., Lotz, J.P., Izrael, V., Krulik, M.

Volltext

Reflexions from the experience of the French CLEOPATRE program and concerns about the status of clinical research on small cell lung cancer von Trillet-Lenoir, Veronique, Lotz, J.P., Le Cesne, A., Roy, P., Avallet, L., Edouard, A.

Volltext